The Harris Texas Warrant Agreement of Immunomedics, Inc. is a legally binding document that outlines the terms and conditions for the purchase of shares of common stock by warrant holders. This agreement allows the warrant holders to acquire a specific number of shares at a predetermined price within a certain time frame. The Harris Texas Warrant Agreement is specific to Immunomedics, Inc., a biotechnology company specializing in the development of innovative therapies for cancer treatment. With this agreement, Immunomedics offers investors the opportunity to purchase shares of its common stock, providing them with a stake in the company's financial performance and growth. There are different types of Harris Texas Warrant Agreements of Immunomedics, Inc. to purchase shares of common stock, including: 1. Standard Warrants: These warrants grant the holder the right to purchase a specified number of shares at a predetermined price during a predetermined period. The expiration date is typically several years in the future. 2. Call Warrants: Call warrants provide investors with the right, but not the obligation, to purchase shares at a predetermined price within a defined time frame. This allows investors to benefit from potential appreciation in the stock price without directly owning the shares. 3. Put Warrants: Put warrants grant investors the right, but not the obligation, to sell their shares back to Immunomedics at a predetermined price within a specific timeframe. Put warrants provide investors with a form of downside protection, as they can sell their shares at a predetermined price even if the market price declines. 4. Covered Warrants: Covered warrants are options issued and guaranteed by a third party to offer investors the ability to purchase or sell Immunomedics' shares at a predetermined price. Covered warrants significantly reduce the counterparty risk for investors. It is important for investors to carefully review the terms and conditions outlined in the Harris Texas Warrant Agreement before considering the purchase of shares of Immunomedics' common stock. The agreement details the exercise price, expiration date, and any other relevant provisions that warrant holders need to be aware of.